PRO ArthMax Dietary Supplement tablets — Class I drug recall D-1327-2014
Terminated recall by HUMAN SCIENCE FOUNDATION, reported 2014-05-28, distributed nationwide. Marketed without an Approved NDA/ANDA; FDA analysis found the product to contain Chlorzoxazone, Nefopam, Diclo
| Recall number | D-1327-2014 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | HUMAN SCIENCE FOUNDATION, Gardena, CA, United States |
| Recall initiated | 2014-01-13 |
| Classified | 2014-05-19 |
| Reported by FDA | 2014-05-28 |
| Terminated | 2014-09-18 |
| Distributed | Nationwide (US) |
| Quantity | 24,268 bottles |
| Reason classes | unapproved product |
| Lot numbers | 01/16, 03/16, 04/16, 08/16, 10/16, 220113, 800213, U133000, U143200, YJK015311 |
Product
PRO ArthMax Dietary Supplement tablets, 750 mg, 120 count bottles, Distributed by Human Science Foundation, Los Angeles, CA
Reason for recall
Marketed without an Approved NDA/ANDA; FDA analysis found the product to contain Chlorzoxazone, Nefopam, Diclofenac, Ibuprofen, Naproxen, and Indomethacin
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1327-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.